Literature DB >> 16491101

Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.

Shane A Perrine1, Brian A Hoshaw, Ellen M Unterwald.   

Abstract

The role of the delta opioid receptor in regulating anxiety-like behavior in male Sprague-Dawley rats was examined. Using an elevated plus maze, the effects of the selective delta opioid receptor antagonist naltrindole (1 or 5 mg kg(-1)) and agonist SNC80 (1, 5 or 20 mg kg(-1)) on anxiety-like behavior were measured. Anxiety was also measured following administration of diazepam (3 mg kg(-1)) and amphetamine (1 mg kg(-1)) and compared to the effects of SNC80. Locomotor activity following administration of naltrindole, SNC80, diazepam, and amphetamine was measured. Finally, the defensive burying paradigm was used to confirm the findings from the elevated plus maze. Results demonstrated that SNC80 produced dose-dependent anxiolytic effects similar to that of the classical antianxiety agent, diazepam. Administration of naltrindole caused anxiogenic behavior in rats further supporting the involvement of the delta opioid receptor system in regulating anxiety. Naltrindole also blocked the anxiolytic effects of SNC80. Amphetamine had no effect on anxiety-like behavior. SNC80 induced hyperactivity similar to amphetamine at the doses tested, while naltrindole and diazepam did not significantly affect locomotor activity. Although SNC80 can increase locomotor activity, control experiments reported herein indicate that hyperlocomotion is not sufficient to produce an anxiolytic response on the elevated plus maze. Together with the results from the defensive burying paradigm, this suggests that the effects of SNC80 on reducing anxiety are independent of its effects on locomotion. Collectively these data show that the delta opioid receptor system can regulate anxiety-like behavior in an anxiolytic (agonist) and anxiogenic (antagonist) manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491101      PMCID: PMC1760715          DOI: 10.1038/sj.bjp.0706686

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Selective interaction of homophtalazine derivatives with morphine.

Authors:  M I Fekete; K Horváth; R Kedves; I Máté; J I Székely; E Szentkuti
Journal:  Eur J Pharmacol       Date:  1997-07-23       Impact factor: 4.432

2.  Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors.

Authors:  M Mas Nieto; S L E Guen; B L Kieffer; B P Roques; F Noble
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Validation of a motor activity system by a robotically controlled vehicle and using standard reference compounds.

Authors:  John P Patterson; Carrie G Markgraf; Maria Cirino; Alan S Bass
Journal:  J Pharmacol Toxicol Methods       Date:  2005 Jul-Aug       Impact factor: 1.950

4.  Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

Authors:  S N Calderon; R B Rothman; F Porreca; J L Flippen-Anderson; R W McNutt; H Xu; L E Smith; E J Bilsky; P Davis; K C Rice
Journal:  J Med Chem       Date:  1994-07-08       Impact factor: 7.446

Review 5.  Cocaine addiction: psychology and neurophysiology.

Authors:  F H Gawin
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

Review 6.  Defensive burying in rodents: ethology, neurobiology and psychopharmacology.

Authors:  Sietse F De Boer; Jaap M Koolhaas
Journal:  Eur J Pharmacol       Date:  2003-02-28       Impact factor: 4.432

7.  Knockout Corner.

Authors:  Kimberly L. Stark; René Hen
Journal:  Int J Neuropsychopharmacol       Date:  1999-06       Impact factor: 5.176

8.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

9.  Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests.

Authors:  C Pesold; D Treit
Journal:  Physiol Behav       Date:  1992-07

Review 10.  Behavioral effects of delta-opioid receptor agonists: potential antidepressants?

Authors:  Daniel C Broom; Emily M Jutkiewicz; Kenner C Rice; John R Traynor; James H Woods
Journal:  Jpn J Pharmacol       Date:  2002-09
View more
  62 in total

1.  Neurochemical, hormonal, and behavioral effects of chronic unpredictable stress in the rat.

Authors:  Brittney M Cox; Fares Alsawah; Peter C McNeill; Matthew P Galloway; Shane A Perrine
Journal:  Behav Brain Res       Date:  2011-01-28       Impact factor: 3.332

Review 2.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  Effects of delta opioid receptors activation on a response inhibition task in rats.

Authors:  Katia Befort; Megan K Mahoney; Carmen Chow; Scott J Hayton; Brigitte L Kieffer; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2010-12-23       Impact factor: 4.530

Review 4.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

5.  δ-opioid and dopaminergic processes in accumbens shell modulate the cholinergic control of predictive learning and choice.

Authors:  Vincent Laurent; Jesus Bertran-Gonzalez; Billy C Chieng; Bernard W Balleine
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

6.  Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress.

Authors:  Hyungwoo Nam; Ramesh Chandra; T Chase Francis; Caroline Dias; Joseph F Cheer; Mary Kay Lobo
Journal:  Neuropsychopharmacology       Date:  2019-05-27       Impact factor: 7.853

7.  The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

Authors:  Diana Vivian Atigari; Kelly Frances Paton; Rajendra Uprety; András Váradi; Amy Frances Alder; Brittany Scouller; John H Miller; Susruta Majumdar; Bronwyn Maree Kivell
Journal:  Neuropharmacology       Date:  2020-12-28       Impact factor: 5.250

8.  Enkephalin knockdown in the basolateral amygdala reproduces vulnerable anxiety-like responses to chronic unpredictable stress.

Authors:  Patrick Bérubé; Jean-François Poulin; Sylvie Laforest; Guy Drolet
Journal:  Neuropsychopharmacology       Date:  2013-11-11       Impact factor: 7.853

9.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

10.  Cocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment.

Authors:  Lisa M Ambrose-Lanci; R C Sterling; Elisabeth J Van Bockstaele
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.